Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sun Pharma explores funding mix for $12 billion Organon deal
Global lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co. The Indian drugmaker is considering swapping Organon bondholders into Sun Pharma debt and a potential euro-denominated bond. Additionally, Sun Pharma plans to raise $3 billion to $4 billion in offshore loans, with deal approvals anticipated by December.
Emcure eyes India growth, global deals amid strong demand
Emcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in India and internationally. New products are expected to drive significant growth. Emcure's partnership with Novo Nordisk for GLP-1 therapies and a pipeline of complex injectables will support future momentum.
'India Throwing Out Communists, We're Stupid To...': US Analyst's Take On Kerala Results Goes Viral
Kerala verdict ignites global buzz as Mark Dubowitz underscores a sharp India–US ideological split
Gokula Education Foundation (Medical) launches RISM, a globally aligned STEM and Management university focused on AI, aerospace, and future-ready skills
Gokula Education Foundation partners with the University at Albany to launch Ramaiah Institute of Science and Management (RISM) in Bengaluru. This new deemed-to-be university will offer next-generation STEM and Management programs, commencing in August 2026, with a focus on industry-aligned education and research.
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garage
Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who built the company from a garage into a global biotech leader, Kiran is ensuring continuity by handing over to a science-driven leader while remaining at the helm during the transition.
Smallcap winners! Wockhardt, Tata Tech, CAMS, other stocks rally up to 11% despite overall market weakness
Smallcap stocks outperformed on Tuesday despite weak broader markets, with Wockhardt, Tata Tech and CAMS gaining up to 11% on strong Q4 earnings. While Nifty 50 slipped below 24,000 amid global concerns, improving momentum and technical indicators signal potential continued strength in the smallcap segment, according to Emkay.
Carlyle buys RCM providers Knack & Equalize for $600 million
Carlyle Group is building a global healthcare revenue cycle management platform. The firm acquired majority stakes in US companies Knack and Equalize. These companies will merge to form a new entity. Carlyle plans to invest significantly and aims for a public listing this fiscal year. This move strengthens their presence in technology and tech-enabled services.
Carlyle buys majority stake in Knack, EqualizeRCM to build AI-led healthcare billing platform
The private equity firm is betting on consolidation in a fragmented US billing services market, with plans to scale via acquisitions and global delivery
Carlyle acquires Knack RCM and Equalize RCM to create an AI-native, global multi-specialty healthcare RCM platform
Global investment firm Carlyle has acquired a majority stake in US healthcare revenue cycle management providers Knack RCM and EqualizeRCM. This move aims to create a global, AI-native, multi-specialty RCM platform. The combined entity will leverage AI and global delivery to enhance operational scale and client outcomes, addressing critical financial risks for healthcare providers.
Mangalam Global Enterprise Receives In-Principle Approval for ESOP Listing of 33,00,000 Equity Shares - scanx.trade
Mangalam Global Enterprise Receives In-Principle Approval for ESOP Listing of 33,00,000 Equity Sharesscanx.trade
India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRI
India is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual property protection for pharmaceuticals. India maintains its intellectual property regime is compliant with international trade rules. This ongoing issue reflects long-standing differences between the two nations. India's stance aims to protect its generics industry and ensure access to affordable healthcare worldwide.
Private Credit’s Retail Risk Draws Scrutiny From Global Watchdog
The world’s top financial stability watchdog is examining the potential risks posed by an influx of retail investors into the $1.8 trillion private credit market, according to a person with knowledge of the matter.